Volume : 09, Issue : 05, May – 2022
Title:
72.REVIEW ON DETAILED STUDY ON GOOD PHARMACY PRACTICE
Authors :
Abdul Basit, Manmeet Singh Saluja*, B. K. Dubey, Deepak Kumar Basedia, Mukesh Kumar Patel
Abstract :
Good Pharmacy Practice (GPP) encompasses a set of standards and procedures designed to ensure that pharmacy services are delivered safely, effectively, and ethically. This review provides a detailed study on GPP, outlining its core principles, including patient safety, quality assurance, and professional conduct. It explores the critical components of GPP, such as medication management, patient counseling, and adherence to regulatory requirements. The review also examines the role of GPP in enhancing healthcare outcomes, its impact on pharmacy practice across various settings, and the challenges faced in its implementation. By synthesizing current guidelines and best practices, this review aims to highlight the importance of GPP in promoting high-quality pharmacy services and improving patient care.
Keywords: Good Pharmacy Practice, Patient safety, Medication management, Quality assurance, Pharmacy standards, Professional conduct, Healthcare outcomes.
Cite This Article:
Number of Downloads : 10
References:
1. World Health Organization. Good pharmacy practice (GPP) in community and hospital settings. World Health Organization. 1996.
2. Pearson GJ. Evolution in the practice of pharmacy—not a revolution! Cmaj 2007 Apr 24;176(9):1295–1296.
3. Toklu HZ, Hussain A. The changing face of pharmacy practice and the need for a new model of pharmacy education. J Young Pharmac 2013 Jun 1;5(2):38–40. https://doi. org/10.1016/j.jyp.2012.09.001.
4. Wiedenmayer K, Summers RS, Mackie CA, Gous AG, Everard M, Tromp D. World Health Organization. Developing pharmacy practice: a focus on patient care: handbook. World Health Organization. 2006.
5. World Health Organization. Joint FIP/WHO guidelines on good pharmacy practice: standards for quality of pharmacy services from the WHO technical report series, No.961, 45th report of the WHO Expert Committee on specifications for pharmaceutical preparations. World Health Organization. 2011.
6. World Health Organization. Joint FIP/WHO Guidelines on Good Pharmacy Practice: Standards for quality of pharmacy services. Annex 8. 2011 .
7. van Mil JW, Schulz M, Tromp TF. Pharmaceutical care, European developments in concepts, implementation, teaching, and research: a review. Pharm World Sci. 2004;26(6):303-11. doi: 10.1007/s11096-004-2849-0.
8. The Order of MOH of Ukraine of 30.05.2013 № 455. On Approval of the Guidelines Good Pharmacy Practice: Quality Standards Pharmacy Services. Weekly Pharm. 2013;27:18-20.
9. Elfituri A, Almoudy A, Jbouda W, Abuflaiga W, Sherif FM. Libya’s Pharmaceutical Situation: A Professional Opinion: Int J Academic Health Med Res. 2018;2(10):5-9.
10. Alsharif SM, Khalf AM, Sughir AA, El-Attug MN, Ammar AA, Kamur RM. Performance assessment of community pharmacist’s intervention in quality of care in Tripoli, Libya: A cross-sectional study: Lebda Med J. 2016;2:61-4.
11. El Oakley RM, Ghrew MH, Aboutwerat AA, Alageli NA, Neami KA, Kerwat RM, et al. Consultation on the Libyan health systems: towards patient-centred services. Libyan J Med. 2013;8. doi: 10.3402/ljm.v8i0.20233.
12. Wiedenmayer K, Summers RS, Mackie CA, Gous AGS, Everard M. Developing a pharmacy practice. A focus on patient care (2006 Edition).
13. Correia JC, Lachat S, Lagger G, Chappuis F, Golay A, Beran D; COHESION Project. Interventions targeting hypertension and diabetes mellitus at community and primary healthcare level in low- and middle-income countries:a scoping review. BMC Public Health. 2019;19(1):1542. doi: 10.1186/s12889-019-7842-6.
14. Vermeulen LC, Kolesar J, Crismon ML, et al. ASHP foundation pharmacy forecast 2018: strategic planning advice for pharmacy departments in hospitals and health systems. Am J Health Syst Pharm. 2018;75(2):23–54. doi: 10.2146/sp180001.
15. Bates I, John C, Bruno A, Fu P, Aliabadi S. An analysis of the global pharmacy workforce capacity. Hum Resour Health. 2016;14(1):61. doi: 10.1186/s12960-016-0158-z.
16. Saleem F. The need of social pharmacy: preparing future pharmacists for practice change. J Pharm Pract Community Med. 2017;3(1):01–02. doi: 10.5530/jppcm.2017.1.1.
17. American Society of Health-System Pharmacists. ASHP statement on the role of health-system pharmacists in public health. Am J Health Syst Pharm. 2008;65(5):462–467. doi: 10.2146/ajhp070399.
18. Kerr A, Strawbridge J, Kelleher C, et al. How can pharmacists develop patient-pharmacist communication skills? A realist review protocol. Syst Rev. 2017;6(1):1–7. doi: 10.1186/s13643-016-0396-0.
19. Zeenny RM, Dimassi A, Sacre H, et al. A cross-sectional survey on community pharmacists readiness to fight COVID-19 in a developing country: knowledge, attitude, and practice in Lebanon. J Pharm Policy Pract. 2021;14(1):1–3. doi: 10.1186/s40545-021-00327-6.
20. Correia JC, Lachat S, Lagger G, Chappuis F, Golay A, Beran D; COHESION Project. Interventions targeting hypertension and diabetes mellitus at community and primary healthcare level in low- and middle-income countries:a scoping review. BMC Public Health. 2019;19(1):1542. doi: 10.1186/s12889-019-7842-6.
21. Hohmeier KC, Wheeler JS, Turner K, Vick JS, Marchetti ML, Crain J, Brookhart A. Targeting adaptability to improve Medication Therapy Management (MTM) implementation in community pharmacy. Implement Sci. 2019;14(1):99. doi: 10.1186/s13012-019-0946-7.
22. Nazar H, Nazar Z, Portlock J, Todd A, Slight SP. A systematic review of the role of community pharmacies in improving the transition from secondary to primary care. Br J Clin Pharmacol. 2015;80(5):936-48. doi: 10.1111/bcp.12718.
23. Barber N, Smith F, Anderson S. Improving quality of health care: the role of pharmacists. Qual Health Care. 1994;3(3):153-8. doi: 10.1136/qshc.3.3.153.
24. Bradley CP. The future role of pharmacists in primary care. Br J Gen Pract. 2009;59(569):891-2. doi: 10.3399/bjgp09X473105.
25. Tonna AP, Stewart D, West B, McCaig D. Pharmacist prescribing in the UK – a literature review of current practice and research. J Clin Pharm Ther. 2007;32(6):545-56. doi: 10.1111/j.1365-2710.2007.00867.
26. Anderson C. Social pharmacy: the current scenario. Indian J Pharm Pract. 2008; 1:1–5.
27. Gerrett D, Stevenson F. A dilemma for ―social‖ pharmacy practice research. Int J Pharm Pract. 1995; 3(2):65–67.
28. Harding G, Taylor K. Defining social pharmacy: it needs its own distinct identity. Int J Pharm Pract. 1993; 2(2):62–63.
29. Palaian S, Poudel A, Alam K, Ibrahim MIM, Mishra P. Initiation of social pharmacy research in Nepal: our experiences. Int J Clin Pharm. 2011; 33(4):591–596.
30. Wertheimer A. Social/behavioral pharmacy—the Minnesota experience. J Clin Pharm Therap. 1991; 16(6)381-383.
31. Abrika OSS, Hassali MAA, Abduelkarem AR. Social pharmacy courses are often neglected in the developing world. Am J Pharm Educ. 2011; 75(4):65b
32. Izham MI, Rahmat AD, Abdul Razak M. Introducing social pharmacy courses to pharmacy students in Malaysia. Med Teach. 1998; 20(2): 122–126.
33. Schaefer M, Leufkens H, Harris M. The teaching of social pharmacy/ pharmacy administration in colleges of pharmacy with special regard to the situation in Germany. J Soc Admin Pharm. 1992; 9(4):141–148.
34. Standards for quality of pharmacy services. Good pharmacy practice. International Pharmaceutical Federation (FIP). The Hague (the Netherlands), september 1997. http://www.fip.org, consulted May 16th 2011.
35. Nicola H. The global pharmacy work force: Systematic review of the literature. Human resource for health. 2009; 7(48): 1478–4491.
36. Aziri B. Job Satisfaction: A Literature Review. Management Research and Practice. 2011; 3
37. 77– 86. [4] Bennadi D. Self-medication: A current challenge. J Basic Clin Pharm. 2013;5(1):19-23. Doi.
38. Babar ZUD, Jamshed S. Social pharmacy strengthening clinical pharmacy: why pharmaceutical policy research is needed in Pakistan? Pharm World Sci. 2008;30(5):617–619.
39. Eickhoff C, Schulz M. Pharmaceutical care in community pharmacies: practice and research in Germany. Ann Pharmacother. 2006;40(4): 729–735.
40. Norris PT. Challenges facing social pharmacy. Res Soc Admin Pharm. 2009;5(3):195–196.
41. Yong FR, Garcia-Cardenas V, Williams KA, Charlie Benrimoj SI. Factors affecting community pharmacist work: A scoping review and thematic synthesis using role theory. Res Social Adm Pharm. 2020;16(2):123-41. doi: 10.1016/j.sapharm.2019.05.001.
42. Hassali MA, Mak VLS, See OG: Pharmacy practice in Malaysia. J Pharmacy Practice Res. 2014;44(3): 125-8. doi: 10.1002/jppr.1024.
43. Bhuvan KC. Curriculum Development: Mismatch Between Supply and Demand. In: Fathelrahman AI, Ibrahim MIM, Alrasheedy AA, Wertheimer AI. Pharmacy Education in the Twenty First Century and Beyond. Elsevier Inc; 2018:285-96. doi: 10.1016/C2016-0-02069-7.
44. Aburuz S, Al-Ghazawi M, Snyder A. Pharmaceutical care in a communitybased practice setting in Jordan: where are we now with our attitudes and perceived barriers? Int J Pharm Pract. 2012;20(2):71-9. doi: 10.1111/j.2042- 7174.2011.00164.x.
45. Hughes CM, Hawwa AF, Scullin C, Anderson C, Bernsten CB, Björnsdóttir I, et al. Provision of pharmaceutical care by community pharmacists: a comparison across Europe. Pharm World Sci. 2010;32(4):472-87. doi: 10.1007/s11096-010-9393-x.